Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (HTSUF)
:HTSUF
Total Valuation
Hisamitsu Pharmaceutical Co has a market cap or net worth of $2.16B. The enterprise value is $350.68B.
Market Cap$2.16B
Enterprise Value$350.68B
Share Statistics
Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,164,894
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hisamitsu Pharmaceutical Co’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.94%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee56.54M
Profits Per Employee7.89M
Employee Count2,759
Asset Turnover0.45
Inventory Turnover2.89
Valuation Ratios
The current PE Ratio of Hisamitsu Pharmaceutical Co is 14.29. Hisamitsu Pharmaceutical Co’s PEG ratio is 1.06.
PE Ratio14.29
PS Ratio0.00
PB Ratio1.18
Price to Fair Value1.12
Price to FCF62.89
Price to Operating Cash Flow23.81
PEG Ratio1.06
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co had revenue of 156.01B and earned 21.76B in profits. Earnings per share was 295.58.
Revenue156.01B
Gross Profit91.20B
Operating Income18.90B
Pretax Income28.69B
Net Income21.76B
EBITDA35.05B
Earnings Per Share (EPS)295.58
Cash Flow
In the last 12 months, operating cash flow was 4.13B and capital expenditures -5.02B, giving a free cash flow of -892.50M billion.
Operating Cash Flow4.13B
Free Cash Flow-892.50M
Free Cash Flow per Share-11.87
Dividends & Yields
Hisamitsu Pharmaceutical Co pays an annual dividend of $0.296, resulting in a dividend yield of 0.01%
Dividend Per Share$0.296
Dividend Yield0.01%
Payout Ratio25.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change30.35%
50-Day Moving Average31.24
200-Day Moving Average28.57
Relative Strength Index (RSI)33.20
Average Volume (3m)3.00
Important Dates
Hisamitsu Pharmaceutical Co upcoming earnings date is Jul 10, 2025, TBA Not Confirmed.
Last Earnings DateJan 9, 2025
Next Earnings DateJul 10, 2025
Ex-Dividend DateFeb 27, 2025
Financial Position
Hisamitsu Pharmaceutical Co as a current ratio of 4.32, with Debt / Equity ratio of 0.90%
Current Ratio4.32
Quick Ratio3.84
Debt to Market Cap0.01
Net Debt to EBITDA-3.16
Interest Coverage Ratio821.57
Taxes
In the past 12 months, Hisamitsu Pharmaceutical Co has paid 6.38B in taxes.
Income Tax6.38B
Effective Tax Rate0.22
Enterprise Valuation
Hisamitsu Pharmaceutical Co EV to EBITDA ratio is 5.71, with an EV/FCF ratio of 38.98.
EV to Sales1.28
EV to EBITDA5.71
EV to Free Cash Flow38.98
EV to Operating Cash Flow10.67
Balance Sheet
Hisamitsu Pharmaceutical Co has $116.64B in cash and marketable securities with ¥2.93B in debt, giving a net cash position of -$113.71B billion.
Cash & Marketable Securities$116.64B
Total Debt¥2.93B
Net Cash-$113.71B
Net Cash Per Share-$1.51K
Tangible Book Value Per Share$3.71K
Margins
Gross margin is 56.65%, with operating margin of 12.11%, and net profit margin of 13.95%.
Gross Margin56.65%
Operating Margin12.11%
Pretax Margin18.39%
Net Profit Margin13.95%
EBITDA Margin22.46%
EBIT Margin18.40%
Analyst Forecast
The average price target for Hisamitsu Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―